Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Clinical trial NCT00316225 · COMPLETED

Trial details

NCT number: NCT00316225
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Mesothelioma Lung Neoplasms

Start date: 2006-12-01
Primary completion: 2009-03-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.